Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis

C Bellia, A Andreadi, I D'Ippolito, L Scola… - Frontiers in …, 2023 - frontiersin.org
Aims After the acute phase of SARS-CoV-2 infection, the onset of glycemic impairment and
diabetes have been reported. Nevertheless, the exact burden of glycemic impairment and …

[HTML][HTML] Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review

YF He, J Ouyang, XD Hu, N Wu, ZG Jiang… - World Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Coronavirus disease 2019 (COVID-19) is one of the current global public
health threats and vaccination is the most effective tool to reduce the spread and decrease …

Molecular mechanisms responsible for diabetogenic effects of Covid-19 infection—induction of autoimmune dysregulation and metabolic disturbances

B Grubišić, L Švitek, K Ormanac, D Sabo… - International journal of …, 2023 - mdpi.com
The COVID-19 pandemic has revealed a significant association between SARS-CoV-2
infection and diabetes, whereby individuals with diabetes are more susceptible to severe …

Type 2 diabetes and Covid-19: Lessons learnt, unanswered questions and hints for the future

P Nazari, P Pozzilli - Diabetes Research and Clinical Practice, 2023 - Elsevier
Abstract Type 2 diabetes (T2DM) and COVID-19 represent a considerable burden of
disease for patients and healthcare systems. New evidence is transpiring detailing the …

Polypharmacy and Antibody Response to SARS-CoV-2 Vaccination in Residents of Long-Term Care Facilities: The GeroCovid Vax Study

C Trevisan, L Haxhiaj, A Malara, A Abbatecola… - Drugs & Aging, 2023 - Springer
Abstract Background and Objective Polypharmacy is common in older adults, particularly
among those living in long-term care facilities. This condition represents a marker of clinical …

Evaluation of antibody response and adverse effects following heterologous COVID-19 vaccine booster with mRNA vaccine among healthcare workers in Indonesia

G Soegiarto, BA Mahdi, L Wulandari, KD Fahmita… - Vaccines, 2023 - mdpi.com
Background: The administration of the third (or booster) dose of COVID-19 vaccine is
important in maintaining protection against SARS-CoV-2 infection or the severity of the …

Sex differences in the efficacy and safety of SARS-CoV-2 vaccination in residents of long-term care facilities: insights from the GeroCovid Vax study

C Trevisan, V Raparelli, A Malara… - Internal and Emergency …, 2023 - Springer
Despite the reported sex-related variations in the immune response to vaccination, whether
the effects of SARS-CoV-2 vaccination differ by sex is still under debate, especially …

Factors Affecting SARS-CoV-2 IgG Production after Vaccination and/or Disease: A Large-Scale Seroprevalence Study

T Karl, A Schuster, LM Stangassinger, T Stiboller… - Vaccines, 2023 - mdpi.com
This study aimed at identifying factors influencing SARS-CoV-2-specific IgG antibody levels
after vaccination and/or infection. Between January 2022 and March 2023, 2000 adults (≥ …

Monovalent SARS-CoV-2 mRNA vaccine does not boost Omicron-specific immune response in diabetic and control pediatric patients

A Sariol, MA Vickers, SM Christensen… - The Journal of …, 2024 - academic.oup.com
While the immunogenicity of SARS-CoV-2 vaccines has been well described in adults,
pediatric populations have been less studied. In particular, children with type 1 diabetes are …

COVID-19 vaccines and blood glucose control: Friend or foe?

W Vena, S Pigni, N Betella, A Navarra… - Human Vaccines & …, 2024 - Taylor & Francis
Purpose To overview the recent literature regarding the relationship between COVID-19
vaccines and glycemic control. Methods Data were extracted from text and tables of all …